Inflammation is emerging as one of the hallmarks of cancer, yet its role in most tumors remains unclear. Whereas a minority of solid tumors are associated with overt inflammation, long-term treatment with non-steroidal anti-inflammatory drugs is remarkably effective in reducing cancer rate and death. This indicates that inflammation might have many as-yet-unrecognized facets, among which an indolent course might be far more prevalent than previously appreciated. In this Review, we explore the various inflammatory processes underlying the development and progression of colorectal cancer and discuss anti-inflammatory means for its prevention and treatment.
Bibliographical noteFunding Information:
Supported by Israeli Science Foundation Centers of Excellence, the European Research Council Framework Programme 7 (294390 PICHO), The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, the I-CORE program of the Israel Science Foundation (41/11) and the Israel Cancer Research Fund (Y.B.-N.).
© 2016 Nature America, Inc. All rights reserved.